Page 6,420«..1020..6,4196,4206,4216,422..6,4306,440..»

Houston Stem Cell Summit Announces Extraordinary Lineup of Keynote Speakers

Posted: Published on October 2nd, 2012

HOUSTON, Oct. 1, 2012 /PRNewswire/ --The Houston Stem Cell Summit will host an extraordinary lineup of keynote speakers who represent the most accomplished stem cell scientists, clinicians and entrepreneurs in the United States. Joining these distinguished speakers will be Governor of Texas, Rick Perry, consistent champion of adult stem cell therapies. (Logo: http://photos.prnewswire.com/prnh/20120831/NY66463LOGO ) The Houston Stem Cell Summit will be held October 26 27 in its namesake city and will highlight the latest therapeutic research regarding the use of adult stem and progenitor cell therapies. The Summit will also provide a forum for entrepreneurs to discuss their latest efforts to commercialize stem cell therapies, and to debate and discuss FDA and other legal and regulatory issues impacting stem cell research and commercialization. Opening Keynote Address October 26, 2012 Arnold I. Caplan, PhD, Professor of Biology and Professor of General Medical Sciences (Oncology) Case Western Reserve University Dr. Caplan has helped shape the direction and focus of adult stem cell research and commercialization. Virtually every adult stem cell company and literally tens of thousands of research papers are based on Dr. Caplan's original and ground breaking research. Professor Caplan is considered to be the "father" of the mesenchymal stem cell … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Houston Stem Cell Summit Announces Extraordinary Lineup of Keynote Speakers

FDA Campaign Aims to Make Online Drug Purchases Safer

Posted: Published on October 2nd, 2012

FRIDAY, Sept. 28 (HealthDay News) -- Understanding and minimizing the risks of buying prescription drugs online are the goals of a new public education campaign by the U.S. Food and Drug Administration. A recent FDA survey of Internet users found that 29 percent said they were unsure of how to safely buy prescription medications online, yet more than 20 percent of respondents said they use the Internet to buy the drugs. The Internet makes it easier for fraudulent and illegal online pharmacies to sell medicines to Americans because they can operate outside the system of federal and state safeguards that protect people from inappropriate or unsafe medicines, according to the FDA. Medicines bought from fraudulent or illegal online pharmacies could be counterfeit, contaminated, past their expiration date, contain the wrong or no active ingredient, or not have FDA approval. Using these medicines could put your health, or the health of your family, at risk, the FDA warned in a news release. Only 3 percent of websites that were reviewed appeared to meet state and federal pharmacy laws, according to the National Association of Boards of Pharmacy, the organization responsible for licensing pharmacies. It can be difficult for consumers to known … Continue reading

Posted in Internet Pharmacy | Comments Off on FDA Campaign Aims to Make Online Drug Purchases Safer

Potential new class of drugs blocks nerve cell death

Posted: Published on October 2nd, 2012

ScienceDaily (Oct. 1, 2012) Diseases that progressively destroy nerve cells in the brain or spinal cord, such as Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), are devastating conditions with no cures. Now, a team that includes a University of Iowa researcher has identified a new class of small molecules, called the P7C3 series, which block cell death in animal models of these forms of neurodegenerative disease. The P7C3 series could be a starting point for developing drugs that might help treat patients with these diseases. These findings are reported in two new studies published the week of Oct. 1 in PNAS Early Edition. "We believe that our strategy for identifying and testing these molecules in animal models of disease gives us a rational way to develop a new class of neuroprotective drugs, for which there is a great, unmet need," says Andrew Pieper, M.D., Ph.D., associate professor of psychiatry at the UI Carver College of Medicine, and senior author of the two studies. About six years ago, Pieper, then at the University of Texas Southwestern Medical Center, and his colleagues screened thousands of compounds in living mice in search of small, drug-like molecules that could boost production of neurons … Continue reading

Posted in Cell Medicine | Comments Off on Potential new class of drugs blocks nerve cell death

Stem-cell advocacy ‘moved the needle’

Posted: Published on October 2nd, 2012

A beautiful, fresh face, Sabrina Cohen can stun you with her charm. But she is far more. This 24-year-old, who has spent 10 years in a wheelchair as a result of a car accident, is battling to raise money for research and therapies that may eventually reverse paralysis and treat central nervous system impairments. A native of Miami Beach, she is one of five leaders being honored by the Palm Beach-based Genetic Policy Institute at its eighth annual World Stem Cell Summit Dec. 4 at the Palm Beach County Convention Center in West Palm Beach. She is receiving the Inspirational Award. This award brings a lot of meaning to my life and the path I have chosen to follow, she says of her founding of the nonprofit Sabrina Cohen Foundation. This provides a platform for my foundation to inspire others and to share my hope for (stem cell) regeneration. Other honorees include CBS 60 Minutes for its hard-hitting programs on unproven stem cell treatments; Susan Solomon, CEO of the New York Stem Cell Foundation; Alliance for Regenerative Medicine; and the Nebraska Coalition for Lifesaving Cures. We recognize the dedicated individuals and organizations that positively impact the cause of stem-cell advancement … Continue reading

Posted in Cell Medicine | Comments Off on Stem-cell advocacy ‘moved the needle’

MRI images transplanted islet cells with help of positively charged nanoparticles

Posted: Published on October 2nd, 2012

Public release date: 1-Oct-2012 [ | E-mail | Share ] Contact: David Eve cellmedicinect@gmail.com Cell Transplantation Center of Excellence for Aging and Brain Repair Tampa, Fla. (Oct. 1, 2012) In a study to investigate the detection by MRI of six kinds of positively-charged magnetic iron oxide nanoparticles designed to help monitor transplanted islet cells, a team of Japanese researchers found that the charged nanoparticles they developed transduced into cells and could be visualized by MRI while three kinds of commercially available nanoparticles used for controls could not. The study is published in a recent special issue of Cell Medicine [3(1)], now freely available on-line at: http://www.ingentaconnect.com/content/cog/cm. "Our data suggests that novel, positively-charged nanoparticles can be useful MRI contrast agents to monitor islet mass after transplantation," said study co-author Hirofumi Noguchi, MD, PhD, of the Department of Gastroenterological Surgery, transplant and Surgical Oncology at the Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. "Significant graft loss immediately after islet transplantation occurs due to immunological and non-immunological events. With MRI an attractive potential tool for monitoring islet mass in vivo, efficient uptake of MRI contrast agent is required for cell labeling." The researchers note that recent techniques of labeling islet … Continue reading

Posted in Cell Medicine | Comments Off on MRI images transplanted islet cells with help of positively charged nanoparticles

Translational Regenerative Medicine: Market Prospects 2012-2022

Posted: Published on October 2nd, 2012

NEW YORK, Oct. 1, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Translational Regenerative Medicine: Market Prospects 2012-2022 http://www.reportlinker.com/p0595030/Translational-Regenerative-Medicine-Market-Prospects-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Blood_Supply,_Tissue_Banking_and_Transplantation Report Details New study shows you commercial potential of regenerative treatments See what the future holds for translational regenerative medicine. Visiongain's updated report lets you assess forecasted sales at overall world market, submarket, product and regional level to 2022. There you investigate the most lucrative areas in that research field, industry and market. Discover prospects for tissue-engineered products, stem cell treatments and gene therapy. We pack our study with information and analysis to help your work and save you time: Access to present and predicted trends, with commercial opportunities and prospects revealed Data and discussions - including our revenue forecasts to 2022 - for your research, analyses and decision making Continue reading here: Translational Regenerative Medicine: Market Prospects 2012-2022 … Continue reading

Posted in Cell Medicine | Comments Off on Translational Regenerative Medicine: Market Prospects 2012-2022

Immune system harnessed to improve stem cell transplant outcomes

Posted: Published on October 2nd, 2012

ScienceDaily (Oct. 1, 2012) A novel therapy in the early stages of development at Virginia Commonwealth University Massey Cancer Center shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant by making the cancer cells easier targets for the immune system. Outlined in the British Journal of Hematology, the Phase II clinical trial was led by Amir Toor, M.D., hematologist-oncologist in the Bone Marrow Transplant Program and research member of the Developmental Therapeutics program at VCU Massey Cancer Center. The multi-phased therapy first treats patients with a combination of the drugs azacitidine and lenalidomide. Azacitidine forces the cancer cells to express proteins called cancer testis antigens (CTA) that immune system cells called T-cell lymphocytes recognize as foreign. The lenalidomide then boosts the production of T-cell lymphocytes. Using a process called autologous lymphocyte infusion (ALI), the T-cell lymphocytes are then extracted from the patient and given back to them after they undergo a stem cell transplant to restore the stem cells' normal function. Now able to recognize the cancer cells as foreign, the T-cell lymphocytes can potentially protect against a recurrence of multiple myeloma following the stem cell transplant. "Every cell in the body … Continue reading

Posted in Cell Therapy | Comments Off on Immune system harnessed to improve stem cell transplant outcomes

Houston Stem Cell Summit Announces Extraordinary Lineup of Keynote Speakers

Posted: Published on October 2nd, 2012

HOUSTON, Oct. 1, 2012 /PRNewswire/ --The Houston Stem Cell Summit will host an extraordinary lineup of keynote speakers who represent the most accomplished stem cell scientists, clinicians and entrepreneurs in the United States. Joining these distinguished speakers will be Governor of Texas, Rick Perry, consistent champion of adult stem cell therapies. (Logo: http://photos.prnewswire.com/prnh/20120831/NY66463LOGO ) The Houston Stem Cell Summit will be held October 26 27 in its namesake city and will highlight the latest therapeutic research regarding the use of adult stem and progenitor cell therapies. The Summit will also provide a forum for entrepreneurs to discuss their latest efforts to commercialize stem cell therapies, and to debate and discuss FDA and other legal and regulatory issues impacting stem cell research and commercialization. Opening Keynote Address October 26, 2012 Arnold I. Caplan, PhD, Professor of Biology and Professor of General Medical Sciences (Oncology) Case Western Reserve University Dr. Caplan has helped shape the direction and focus of adult stem cell research and commercialization. Virtually every adult stem cell company and literally tens of thousands of research papers are based on Dr. Caplan's original and ground breaking research. Professor Caplan is considered to be the "father" of the mesenchymal stem cell … Continue reading

Posted in Cell Therapy | Comments Off on Houston Stem Cell Summit Announces Extraordinary Lineup of Keynote Speakers

Experimental Stem Cell Therapy May Help Burn Victims

Posted: Published on October 2nd, 2012

For more than 40 years, Lesley Kelly of Glasgow, Scotland, lived with third-degree burns that stretched over 60 percent of her body. Kelly was 2 years old when she fell into a bathtub filled with hot water that scorched most of the right side of her body. She lost full range of motion around many of her joints. "When you have bad scarring, the buildup is very thick and has no elasticity," said Kelly, 45, whose right elbow was most affected by the buildup of scar tissue. "The problem with thermal burn scarring [is that] it's hard to get the range of motion." Kelly underwent numerous reparative surgeries through the years, but the scar tissue continued to grow back. The procedures did not lessen the look of her scars. In 2011, Kelly underwent a new, experimental procedure that used stem cells from her own fat tissue to repair the buildup around her right elbow. Surgeons cleaned the scar buildup around the elbow and used liposuction to pull fat from off Kelly's waist. They separated the fat cells from the stem and regenerative cells, which were then injected into the wound on Kelly's arm. The procedure took less than two hours. … Continue reading

Posted in Cell Therapy | Comments Off on Experimental Stem Cell Therapy May Help Burn Victims

New Therapy May Help Burn Victims

Posted: Published on October 2nd, 2012

Lesley Kelly, 45, underwent stem cell therapy to repair scar tissue buildup in her right arm. (Cytori Therapeutics, Inc.) By Lara Salahi, ABC News For more than 40 years, Lesley Kelly of Glasgow, Scotland, lived with third-degree burns that stretched over 60 percent of her body. Kelly was 2 years old when she fell into a bathtub filled with hot water that scorched most of the right side of her body. She lost full range of motion around many of her joints. "When you have bad scarring, the buildup is very thick and has no elasticity," said Kelly, 45, whose right elbow was most affected by the buildup of scar tissue. "The problem with thermal burn scarring [is that] it's hard to get the range of motion." Kelly underwent numerous reparative surgeries through the years, but the scar tissue continued to grow back. The procedures did not lessen the look of her scars. In 2011, Kelly underwent a new, experimental procedure that used stem cells from her own fat tissue to repair the buildup around her right elbow. Surgeons cleaned the scar buildup around the elbow and used liposuction to pull fat from off Kelly's waist. They separated the fat … Continue reading

Posted in Cell Therapy | Comments Off on New Therapy May Help Burn Victims

Page 6,420«..1020..6,4196,4206,4216,422..6,4306,440..»